| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Winship Cancer Institute and the Department of Biostatistics, Rollins School of Public Health, Emory University School of Medicine, Atlanta, Georgia.
Correspondence: Address correspondence and reprint requests to: Grant W. Carlson, MD, Winship Cancer Institute, 1365B Clifton Rd., Atlanta, GA 30322; Fax: 404-778-4255; E-mail: grant_carlson{at}emory.org
Background: Long-term follow-up of the use of skin-sparing mastectomy (SSM) in the treatment of breast cancer is presented to determine the impact of local recurrence (LR) on survival.
Methods: A total of 539 patients were treated for 565 cases of breast cancer by SSM and immediate breast reconstruction from January 1, 1989 to December 31, 1998. The American Joint Committee on Cancer pathological staging was stage 0 175 (31%), stage I 135 (23.9%), stage II 173 (30.6%), stage III 54 (9.6%), stage IV 8 (1.4%), and recurrent 20 (3.5%). The mean follow-up was 65.4 months (range, 23.786.3 months). Five patients were lost to follow-up.
Results: Thirty-one patients developed a LR during the follow-up including five who received adjuvant radiation. The distribution of LR stratified by cancer stage was stage 0 1, stage I 5, stage II 17, stage III 6, and recurrent 2. The overall LR was 5.5%. Twenty-four patients (77.4%) developed a systemic relapse and 7 (22.6%) patients remained free of recurrent disease at a mean follow-up of 78.1 months. The cancer stage of those remaining disease free was stage 0 1 (100%), stage I 4 (80%), and stage II 2 (11.8%).
Conclusions: LR of breast cancer after SSM is not always associated with systemic relapse.
Key Words: Breast Cancer Skin-sparing mastectomy Recurrence
This article has been cited by other articles:
![]() |
D. Cao, T. N. Tsangaris, N. Kouprina, L. S.-F. Wu, C. M. Balch, R. Vang, and P. Argani The Superficial Margin of the Skin-Sparing Mastectomy for Breast Carcinoma: Factors Predicting Involvement and Efficacy of Additional Margin Sampling Ann. Surg. Oncol., May 1, 2008; 15(5): 1330 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Stolier and J. Wang Terminal Duct Lobular Units are Scarce in the Nipple: Implications for Prophylactic Nipple-Sparing Mastectomy: Terminal Duct Lobular Units in the Nipple Ann. Surg. Oncol., February 1, 2008; 15(2): 438 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Son, B. S. Kwak, J. K. Kim, H. J. Kim, S. J. Hong, J. S. Lee, U. K. Hwang, H. S. Yoon, and S. H. Ahn Changing patterns in the clinical characteristics of korean patients with breast cancer during the last 15 years. Arch Surg, February 1, 2006; 141(2): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Torresan, C. C. dos Santos, H. Okamura, and M. Alvarenga Evaluation of Residual Glandular Tissue After Skin-Sparing Mastectomies Ann. Surg. Oncol., December 1, 2005; 12(12): 1037 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Singletary and G. L. Robb Oncologic Safety of Skin-Sparing Mastectomy Ann. Surg. Oncol., March 1, 2003; 10(2): 95 - 97. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |